Replies to post #7110 on GTC Biotherapeutics (fka GTCB)

[DewDiligence]

Reference List of rFVIIa Papers

[Added abstract on pharmacoeconomic rationale
for FVIIa in hemophilia with inhibitors.]


Prophylactic use in hereditary hemophilia
#msg-25160331von Willebrand disease
#msg-22471666
#msg-19404190
#msg-15650473


Acquired hemophilia
#msg-26121985 Postpartum hemorrhage (European registry)
#msg-24267861 Negative review from Italy
#msg-23278399 Reversing effects of anticoagulants
#msg-23666744 Postpartum hemorrhage
#msg-21829544 CABG
#msg-19965112 Aortic Dissection
#msg-18991424 Meta-analysis in acquired hemophilia
#msg-16035848 Pediatric hemorrhage
#msg-16035824 CABG
#msg-15749216 Hepatic trauma
#msg-15679338 Reversing Plavix bleeding
#msg-14833495 Postcardiotomy bleeding
#msg-13784060 Reversing Lepirudin (Refludan) bleeding


Trauma and military settings
#msg-24304079 Profile of chief military surgeon
#msg-22196042
#msg-19667761
#msg-15971893
#msg-14921693
#msg-13925693


Intracerebral hemorrhage
#msg-19364652 Review
#msg-15742148 Non-surgical ICH
#msg-15122036
#msg-14833043
#msg-14634515


Economic analysis
#msg-27139814
#msg-16326768
#msg-16169770
#msg-15971893
#msg-15063643


Miscellaneous
Everything you wanted to know about FVIIa in practice
#msg-25220261 FVIIa FoB’s (highly technical)
#msg-22375431 FVIII+FVIIa combination therapy
#msg-14700217 FVIIa analogs
#msg-14673432 Titration method